VEGFA and chronic kidney disease: The study indicated that renoprotective effects after ELP-VEGF therapy was largely driven by modulation of renal macrophages toward the anti-inflammatory M2 phenotype, restoring VEGF signaling and sustaining improvement of renal function and microvascular integrity in CKD [81].